Literature DB >> 3791076

Cardiopulmonary effects of xylazine and yohimbine in laterally recumbent sheep.

T J Doherty, P J Pascoe, W N McDonell, G Monteith.   

Abstract

The effects of yohimbine (0.125 mg/kg) on cardiopulmonary parameters in six adult, xylazine treated (0.15 mg/kg), laterally recumbent sheep were studied. Following collection of baseline data, xylazine was administered intravenously and data were collected five and fifteen minutes later. At twenty minutes post-xylazine either yohimbine (0.125 mg/kg) or saline was given and further collection of data occurred at 25, 30, 40 and 50 minutes. Xylazine administration resulted in significant (P less than 0.05) respiratory depression, as reflected by a decrease in arterial oxygen partial pressure (PaO2). No significant changes in haemodynamic variables were observed. Yohimbine produced a significant improvement in PaO2 at the 50 minute period and abolished the paradoxical respiratory pattern when present. The results indicated that yohimbine can be used as an antagonist to control the duration of xylazine induced respiratory depression, although the degree of reversal was less than is clinically desirable.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3791076      PMCID: PMC1255257     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  17 in total

Review 1.  Central alpha-adrenergic systems as targets for hypotensive drugs.

Authors: 
Journal:  Rev Physiol Biochem Pharmacol       Date:  1978       Impact factor: 5.545

2.  Cardiovascular and respiratory effects of xylazine in sheep.

Authors:  M A Aziz; S S Carlyle
Journal:  Zentralbl Veterinarmed A       Date:  1978-04

Review 3.  Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor.

Authors:  M R Goldberg; D Robertson
Journal:  Pharmacol Rev       Date:  1983-09       Impact factor: 25.468

Review 4.  Alpha-adrenoceptor subclassification.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1981       Impact factor: 5.545

5.  Vascular smooth muscle contraction initiated by postsynaptic alpha 2-adrenoceptor activation is induced by an influx of extracellular calcium.

Authors:  J C Van Meel; A De Jonge; H O Kalkman; B Wilffert; P B Timmermans; P A Van Zwieten
Journal:  Eur J Pharmacol       Date:  1981-01-16       Impact factor: 4.432

6.  Cardiovascular effects of yohimbine in anaesthetized dogs.

Authors:  M Andréjak; M Ward; H Schmitt
Journal:  Eur J Pharmacol       Date:  1983-10-28       Impact factor: 4.432

7.  Effect of yohimbine on xylazine-ketamine anesthesia in cats.

Authors:  W H Hsu; Z X Lu
Journal:  J Am Vet Med Assoc       Date:  1984-10-15       Impact factor: 1.936

8.  Effect of yohimbine on xylazine-induced central nervous system depression in dogs.

Authors:  W H Hsu
Journal:  J Am Vet Med Assoc       Date:  1983-04-01       Impact factor: 1.936

9.  Influence of yohimbine on xylazine-induced depression of central nervous, gastrointestinal and cardiovascular function in the calf.

Authors:  C L Guard; W S Schwark
Journal:  Cornell Vet       Date:  1984-10

10.  Functional characterization of central alpha-adrenoceptors by yohimbine diastereomers.

Authors:  L Hedler; G Stamm; R Weitzell; K Starke
Journal:  Eur J Pharmacol       Date:  1981-03-05       Impact factor: 4.432

View more
  1 in total

1.  Clostridium perfringens epsilon-toxin acts on MDCK cells by forming a large membrane complex.

Authors:  L Petit; M Gibert; D Gillet; C Laurent-Winter; P Boquet; M R Popoff
Journal:  J Bacteriol       Date:  1997-10       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.